MUKUL DALVI;TEVA BRANDED PHARMACEUTICAL PRODUCTS R& D INC.;SEAH KEE TEE
发明人:
MUKUL DALVI,SEAH KEE TEE
申请号:
IL25349917
公开号:
IL253499D0
申请日:
2017.07.16
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of fluticasone propionate per actuation is less than 100 μg; and wherein the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose. A method of treating a patient includes administering to a patient a dry powder medicament having fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of fluticasone propionate per actuation is less than 100 μg; and wherein the dose provides a baseline-adjusted FEV1 in a patient of more than 150 mL within 30 minutes of receiving the dose.